BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 32458259)

  • 1. BRAF V600E mutation detection in hairy cell leukemia-utility of archival DNA from bone marrow aspirate/imprint smear and amplification refractory mutation system.
    Naseem S; Gupta O; Binota J; Varma N; Varma S; Malhotra P
    Mol Biol Rep; 2020 Jun; 47(6):4365-4372. PubMed ID: 32458259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical analysis using a BRAF V600E mutation specific antibody is highly sensitive and specific for the diagnosis of hairy cell leukemia.
    Wang XJ; Kim A; Li S
    Int J Clin Exp Pathol; 2014; 7(7):4323-8. PubMed ID: 25120816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of allele-specific PCR and immunohistochemistry for the detection of BRAF V600E mutations in hairy cell leukemia.
    Brown NA; Betz BL; Weigelin HC; Elenitoba-Johnson KS; Lim MS; Bailey NG
    Am J Clin Pathol; 2015 Jan; 143(1):89-99. PubMed ID: 25511147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of a BRAF V600E mutation-specific antibody for the diagnosis of hairy cell leukemia.
    Andrulis M; Penzel R; Weichert W; von Deimling A; Capper D
    Am J Surg Pathol; 2012 Dec; 36(12):1796-800. PubMed ID: 22531170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BRAF mutation detection in hairy cell leukaemia from archival haematolymphoid specimens.
    Thomas C; Amanuel B; Finlayson J; Grieu-Iacopetta F; Spagnolo DV; Erber WN
    Pathology; 2015 Jun; 47(4):349-54. PubMed ID: 25938346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The utility of BRAF V600E mutation-specific antibody VE1 for the diagnosis of hairy cell leukemia.
    Uppal G; Ly V; Wang ZX; Bajaj R; Solomides CC; Banks PM; Medeiros LJ; Peiper SC; Gong JZ
    Am J Clin Pathol; 2015 Jan; 143(1):120-5. PubMed ID: 25511150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comprehensive immunophenotypic marker analysis of hairy cell leukemia in paraffin-embedded bone marrow trephine biopsies--a tissue microarray study.
    Tóth-Lipták J; Piukovics K; Borbényi Z; Demeter J; Bagdi E; Krenács L
    Pathol Oncol Res; 2015 Jan; 21(1):203-11. PubMed ID: 24903677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemistry for BRAF V600E in the Differential Diagnosis of Hairy Cell Leukemia vs Other Splenic B-Cell Lymphomas.
    Turakhia S; Lanigan C; Hamadeh F; Swerdlow SH; Tubbs RR; Cook JR
    Am J Clin Pathol; 2015 Jul; 144(1):87-93. PubMed ID: 26071465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of BRAF mutations in patients with hairy cell leukemia and related lymphoproliferative disorders.
    Blombery PA; Wong SQ; Hewitt CA; Dobrovic A; Maxwell EL; Juneja S; Grigoriadis G; Westerman DA
    Haematologica; 2012 May; 97(5):780-3. PubMed ID: 22133769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hairy cell leukaemia with unusual BRAF mutations.
    Maitre E; Macro M; Troussard X
    J Cell Mol Med; 2023 Sep; 27(17):2626-2630. PubMed ID: 37530550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of methodologies for the detection of
    Cardus B; Colling R; Hamblin A; Soilleux E
    J Clin Pathol; 2019 Jun; 72(6):406-411. PubMed ID: 30872385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Requisite analytic and diagnostic performance characteristics for the clinical detection of BRAF V600E in hairy cell leukemia: a comparison of 2 allele-specific PCR assays.
    Brown NA; Weigelin HC; Bailey N; Laliberte J; Elenitoba-Johnson KS; Lim MS; Betz BL
    Appl Immunohistochem Mol Morphol; 2015 Sep; 23(8):590-600. PubMed ID: 24503706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid detection and quantitation of BRAF mutations in hairy cell leukemia using a sensitive pyrosequencing assay.
    Verma S; Greaves WO; Ravandi F; Reddy N; Bueso-Ramos CE; O'Brien S; Thomas DA; Kantarjian H; Medeiros LJ; Luthra R; Patel KP
    Am J Clin Pathol; 2012 Jul; 138(1):153-6. PubMed ID: 22706871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone marrow and splenic histology in hairy cell leukaemia.
    Wotherspoon A; Attygalle A; Mendes LS
    Best Pract Res Clin Haematol; 2015 Dec; 28(4):200-7. PubMed ID: 26614898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The BRAF V600E mutation in hairy cell leukemia and other mature B-cell neoplasms.
    Arcaini L; Zibellini S; Boveri E; Riboni R; Rattotti S; Varettoni M; Guerrera ML; Lucioni M; Tenore A; Merli M; Rizzi S; Morello L; Cavalloni C; Da Vià MC; Paulli M; Cazzola M
    Blood; 2012 Jan; 119(1):188-91. PubMed ID: 22072557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simple genetic diagnosis of hairy cell leukemia by sensitive detection of the BRAF-V600E mutation.
    Tiacci E; Schiavoni G; Forconi F; Santi A; Trentin L; Ambrosetti A; Cecchini D; Sozzi E; Francia di Celle P; Di Bello C; Pulsoni A; Foà R; Inghirami G; Falini B
    Blood; 2012 Jan; 119(1):192-5. PubMed ID: 22028477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Difference of genomic copy numbers alterations between hairy cell leukemia-variant and classical hairy cell leukemia: a pilot retrospective study in Chinese.
    Zhang R; Wu Y; Wang X; Lu X; Li Y; Li S; Yan X
    Int J Med Sci; 2020; 17(3):325-331. PubMed ID: 32132867
    [No Abstract]   [Full Text] [Related]  

  • 18. Identification of the BRAF V600E mutation in Japanese patients with hairy cell leukemia and related diseases using a quenching probe method.
    Itamura H; Ide M; Sato A; Sueoka-Aragane N; Sueoka E; Nishida A; Masunari T; Aoki S; Takizawa J; Suzumiya J; Kimura S
    Int J Hematol; 2018 Oct; 108(4):416-422. PubMed ID: 30043333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical and molecular characteristics and prognosis of classical hairy cell leukemia and hairy cell leukemia variant].
    Wei C; Jin XX; Cai H; Wang X; Zhuang JL; Zhou DB
    Zhonghua Nei Ke Za Zhi; 2023 Apr; 62(4):416-421. PubMed ID: 37032137
    [No Abstract]   [Full Text] [Related]  

  • 20. Hairy cell leukemia: 2020 update on diagnosis, risk stratification, and treatment.
    Maitre E; Cornet E; Troussard X
    Am J Hematol; 2019 Dec; 94(12):1413-1422. PubMed ID: 31591741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.